Foghorn Therapeutics Inc. Balance Sheet

Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 255.59M519.77M404.88M285.92M283.98M
Current Assets
Cash & Equivalents 92.80M101.14M52.21M80.34M55.45M
Receivables - Other 300.00M
Prepaid Assets 4.92M5.27M5.60M6.12M5.85M
Current Assets 190.69M459.56M351.40M240.18M249.60M
Non-Current Assets
Property, Plant & Equipment (Net) 19.53M17.56M15.31M12.96M9.96M
Other Non-Current Assets 1.73M2.40M2.38M1.71M1.71M
Non-Current Assets 64.91M60.21M53.48M45.73M34.38M
Liabilities
Current Liabilities
Accounts Payables 9.16M9.56M11.00M9.11M8.53M
Payables 9.16M9.56M11.00M9.11M8.53M
Accumulated Expenses 9.16M9.56M11.00M9.11M8.53M
Other Accumulated Expenses 0.14M0.39M0.32M0.04M0.00M
Current Leases 3.98M6.99M5.97M8.52M9.07M
Current Deferred Revenue 2.02M28.32M32.82M34.55M45.61M
Total Current Liabilities 18.85M48.69M55.20M58.44M66.99M
Non-Current Liabilities
Non-Current Debt 19.65M
Non-Current Deffered Revenue 12.55M322.73M304.00M268.12M234.46M
Operating Leases 62.34M58.33M51.51M45.07M28.06M
Other Non-Current Liabilities 0.14M0.03M
Total Non-Current Liabilities 422.76M404.74M
Liabilities
Total Liabilities 109.41M422.90M404.77M363.11M329.51M
Shareholder's Equity
Total Debt 19.65M
Common Equity 146.19M96.87M0.11M-77.19M-45.53M
Shareholder's Equity 146.19M96.87M0.11M-77.19M-45.53M
Liabilities and Shareholders Equity 255.59M519.77M404.88M285.92M283.98M
Retained Earnings -162.94M-264.26M-373.14M-471.56M-558.18M